Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wulin Xu
Lentivirus-Mediated Silencing of HOTAIR lncRNA Restores Gefitinib Sensitivity by Activating Bax/Caspase-3 and Suppressing TGF-α/EGFR Signaling in Lung Adenocarcinoma
Oncology Letters
Cancer Research
Oncology
Overexpression of Forkhead Box M1 and Urokinase‑type Plasminogen Activator in Gastric Cancer Is Associated With Cancer Progression and Poor Prognosis
Oncology Letters
Cancer Research
Oncology
Related publications
TAZ Inhibition Restores Sensitivity of Cisplatin via AKT/mTOR Signaling in Lung Adenocarcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Lentivirus-Mediated Silencing of the PTC1 and PTC2 Genes Promotes Recovery From Spinal Cord Injury by Activating the Hedgehog Signaling Pathway in a Rat Model
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Silencing of SNX1 by siRNA Stimulates the Ligand-Induced Endocytosis of EGFR and Increases EGFR Phosphorylation in Gefitinib-Resistant Human Lung Cancer Cell Lines
International Journal of Oncology
Cancer Research
Oncology
lncRNA LOC100132354 Promotes Angiogenesis Through VEGFA/VEGFR2 Signaling Pathway in Lung Adenocarcinoma
Cancer Management and Research
Oncology
Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
Cancer Research
Cancer Research
Oncology
A Case of Small Cell Lung Cancer Transformation From EGFR-Mutant Lung Adenocarcinoma With Primary Resistance to Gefitinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates P38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy
PLoS ONE
Multidisciplinary